CAR-T and the Rise of Cellicon Valley

Irvine Auditorium and Perelman Quadrangle
3401/3417 Spruce Street, Philadelphia, PA 19104  

May 9, 2019-May 10, 2019

Presented by Children's Hospital of Philadelphia and Penn's Abramson Cancer Center


CAR T-cell therapy represents a turning point in the history of human medicine, a genuine revolution in our approach to disease within the field of cellular therapy and transplant. The recent approval of chimeric antigen receptor (CAR) T cells offers even patients with highly chemo-refractory hematologic malignancies additional treatment options. World experts in CAR T-cellular therapy and hematopoietic stem cell transplantation (HSCT) have been assembled to discuss the development and implementation of this therapy and to weigh in on current applications, best practices, novel strategies and future developments for CAR T cells.

Register now and receive “early bird” rates through March 15, 2019.

Learn more and register.